Wolverhampton Wanderers on Tuesday confirmed that Super Eagles goalkeeper Carl Ikeme will retain his No.1 jersey for the 2017/2018 season despite his battles against chronic leaukamia.
Ikeme was diagnosed of the blood cancer following tests run by the club last week at the start of pre-season.
“Wolves can confirm that Carl Ikeme will remain listed as the club’s number one for the 2017/18 season,” the club said in a statement on their official website.
“Following the devastating news, Wolves are today announcing a number of initiatives the club is running at the first game of the season to show our support for Carl and to raise money for the well-known Birmingham-based charity Cure Leukaemia.
“With a bumper crowd expected for the Wolves v Middlesbrough match we are committing to donate 10% of gate receipts to Cure Leukaemia for all home match tickets purchased for this game. The charity will also be located around the ground doing a bucket collection to raise more money.
“The 2017/18 Goalkeeper kits are now on sale in the Molineux Megastore and online at wolvesmegastore.co.uk . If you have “Ikeme 1” printed on the back of any replica shirt this season we’ll donate all profits from the printing to Cure Leukaemia also.
“For any fans who have already had this printed on a 2017/18 replica shirt we will retrospectively make the donation.
“To show our support for Carl at the game we’ll be running a number of activities including a large banner and some fan flags in the North and South Banks as well as messages of support on the LED boards.
“We’ll also have a get well card available in Wolfie’s Den for fans to sign and a station for young fans to come in and make their own cards which we will forward on to Carl.
“Thank you to everyone who has sent in messages of support. We will be collating them all and passing them on to Carl and his family at an appropriate time.”
Wednesday, 12 July 2017
Carl Ikeme To Retain Wolves’ No.1 Jersey As Club Raise Leukaemia Funds
Sports
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment